Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney disease
Open Access
- 22 January 2013
- journal article
- Published by Springer Science and Business Media LLC in BMC Nephrology
- Vol. 14 (1), 23
- https://doi.org/10.1186/1471-2369-14-23
Abstract
Background: Galectin-9 (Gal-9) induces apoptosis in activated T helper 1 (TH1) cells as a ligand for T cell immunoglobulin mucin-3 (Tim-3). Gal-9 also inhibits the G1 phase cell cycle arrest and hypertrophy in db/db mice, the hallmark of early diabetic nephropathy, by reversing the high glucose-induced up-regulation of cyclin dependent kinase inhibitors such as p27Kip1and p21Cip1.Methods: We investigated the serum levels of Gal-9 in the patients with type 2 diabetes and various stages of chronic kidney disease (CKD) (n=182).Results: Serum Gal-9 levels in the patients with type 2 diabetes were 131.9 ± 105.4 pg/ml and Log10Gal-9 levels significantly and positively correlated with age (r=0.227, p=0.002), creatinine (r=0.175, p=0.018), urea nitrogen (r=0.162, p=0.028) and osmotic pressure (r=0.187, p=0.014) and negatively correlated with estimated glomerular filtration rate (eGFR) (r=−0.188, p=0.011). Log10Gal-9 levels increased along with the progression of GFR categories of G1 to G4, and they were statistically significant by Jonckheere-Terpstra test (p=0.012). Log10Gal-9 levels remained similar levels in albuminuria stages of A1 to A3.Conclusion: The elevation of serum Gal-9 in the patients with type 2 diabetes is closely linked to GFR and they may be related to the alteration of the immune response and inflammation of the patients with type 2 diabetes and CKD.Keywords
This publication has 21 references indexed in Scilit:
- Protein release through nonlethal oncotic pores as an alternative nonclassical secretory pathwayBMC Cell Biology, 2011
- Tim3 binding to galectin-9 stimulates antimicrobial immunityThe Journal of Experimental Medicine, 2010
- Galectin-9/TIM-3 Interaction Regulates Virus-Specific Primary and Memory CD8+ T Cell ResponsePLoS Pathogens, 2010
- A Crucial Role for Kupffer Cell-Derived Galectin-9 in Regulation of T Cell Immunity in Hepatitis C InfectionPLOS ONE, 2010
- Revised Equations for Estimated GFR From Serum Creatinine in JapanAmerican Journal of Kidney Diseases, 2009
- The Tim-3 ligand galectin-9 negatively regulates CD8+ alloreactive T cell and prolongs survival of skin graftCellular Immunology, 2007
- Regulatory mechanisms of galectin‐9 and eotaxin‐3 synthesis in epidermal keratinocytes: possible involvement of galectin‐9 in dermal eosinophilia of Th1‐polarized skin inflammationAllergy, 2006
- The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunityNature Immunology, 2005
- Galectin-9 Inhibits Glomerular Hypertrophy in db/db Diabetic Mice via Cell-Cycle–Dependent MechanismsJournal of the American Society of Nephrology, 2005
- Galectins: A family of animal β-galactoside-binding lectinsCell, 1994